Topic: Musculoskeletal disorders
Conditions
Interventions
Participants are randomly allocated to one of three groups.
Group 1: Participants are given an advice sheet and a physiotherapy department leaflet (control group)
Group 2: Participants are provided w
Sponsors
Nottingham University Hospitals NHS Trust
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 70 years at the time of fracture 2. Able to give informed consent 3. Any fracture of the distal radius within 3cm of the radiocarpal joint will be considered for inclusion (including intraarticular fractures, fractures with comminution, associated ulnar styloid fracture, dorsal and volar displacement patterns) provided it has been deemed suitable for conservative management by the treating physician. 4. Fracture treated with immobilisation (plaster of paris / fibreglass cast / splint) worn constantly for between 5 and 7 weeks 5. English should be the patient's first language
Exclusion criteria
Exclusion criteria: 1. A fracture which extends beyond 3 cm of the radiocarpal joint 2. Any patient with bilateral fractures 3. A fracture which has been immobilised outside of the range of 5 and 7 weeks 4. Any patient who is deemed to be unlikely to be able to adhere to the trial procedure or complete the questionnaires (e.g. drug dependence or cognitive impairment) 5. Current participation in another ongoing study 6. Evidence of complex regional pain syndrome 7. Post plaster stiffness of the fingers which prevents the patient from being able to place their hand flat on a tabletop 8. Any previous fracture of the wrist or carpal bones whether treated operatively or conservatively
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms and ability in the affected arm are measured using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire at baseline, 6 , 12 and 52 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. EQ5D at baseline, 6 , 12 and 52 weeks 2. Patient Evaluation Measure (PEM) at baseline, 6, 12 and 52 weeks 3. Routine Outcome Measures (ROM) at 6, 12 and 52 weeks | — |
Countries
England, United Kingdom
Contacts
Public ContactJessica Nightingale
Outcome results
None listed